Table 2.
Comparison between five groups
N | Serum L1CAM expression | P value* | |
---|---|---|---|
Mean ± SD | |||
GC | 148 | 28.687 ±14.162 | <0.001 |
Early-stage GC (0+I+II) | 47 | 35.265 ±16.300 | <0.001 |
Advanced-stage GC (III+IV) | 101 | 25.625 ±11.951 | <0.001 |
EJA | 59 | 34.506 ±19.408 | <0.001 |
Early-stage EJA (0+I+II) | 13 | 33.522 ±16.972 | 0.038 |
Advanced-stage EJA (III+IV) | 46 | 34.784 ±20.207 | <0.001 |
Normal controls | 148 | 49.325 ±31.722 |
*Compared with normal controls. GC: Gastric cancers; EJA: Esophagogastric junction adenocarcinomas.